OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Oct 14

PMID 36232392

Authors

Francesca Lantieri

Tiziana Bachetti

Affiliations

Soon will be listed here.

Abstract

Oncostatin M (OSM) is a member of the interleukin-6 (IL-6) family of cytokines and can bind two different receptors, Leukemia inhibitory factor receptor (LIFR) and Oncostatin M receptor (OSMR), through a complex containing the common glycoprotein 130 (gp130) subunit [...].

Citing Articles

Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid.

Wang C, Feng Y, Chen Y, Lin X, Li X Front Endocrinol (Lausanne). 2025; 16:1525392.

PMID: 39996063 PMC: 11847672. DOI: 10.3389/fendo.2025.1525392.

Crotonylation-Related Prognostic Model of Esophageal Squamous Cell Carcinoma Based on Transcriptome Analysis and Single-Cell Sequencing Analysis.

Lin R, Chen R, Lin F Int J Gen Med. 2025; 18:415-436.

PMID: 39895826 PMC: 11784406. DOI: 10.2147/IJGM.S493800.

Gene-environment interactions in the influence of maternal education on adolescent neurodevelopment using ABCD study.

Shi R, Chang X, Banaschewski T, Barker G, Bokde A, Desrivieres S Sci Adv. 2024; 10(46):eadp3751.

PMID: 39546599 PMC: 11567010. DOI: 10.1126/sciadv.adp3751.

The microenvironmental factors induced invasive tumor cells in glioblastoma.

Zhang J, Li J, Qi R, Li S, Geng X, Shi H Heliyon. 2024; 10(16):e35770.

PMID: 39253204 PMC: 11381606. DOI: 10.1016/j.heliyon.2024.e35770.

OSMR is a potential driver of inflammation in amyotrophic lateral sclerosis.

Chen W, Jiang S, Li S, Li C, Xu R Neural Regen Res. 2024; 19(11):2513-2521.

PMID: 38526287 PMC: 11090450. DOI: 10.4103/1673-5374.391309.

References

Bernstein C, Kuenzig M, Coward S, Nugent Z, Nasr A, El-Matary W . Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study. J Pediatr. 2021; 233:98-104.e2. DOI: 10.1016/j.jpeds.2021.01.060. View

Fernandes B, Rosa-Goncalves D, Magro F, Costa L, Bernardes M . Musculoskeletal manifestations in a Portuguese cohort of 235 inflammatory bowel disease patients. ARP Rheumatol. 2022; 1(2):137-141. View

Lieder B, Zaunschirm M, Holik A, Ley J, Hans J, Krammer G . The Alkamide -Pellitorine Targets PPARγ via TRPV1 and TRPA1 to Reduce Lipid Accumulation in Developing 3T3-L1 Adipocytes. Front Pharmacol. 2017; 8:316. PMC: 5449966. DOI: 10.3389/fphar.2017.00316. View

Lorchner H, Adrian-Segarra J, Waechter C, Wagner R, Goes M, Brachmann N . Concomitant Activation of OSM and LIF Receptor by a Dual-Specific hlOSM Variant Confers Cardioprotection after Myocardial Infarction in Mice. Int J Mol Sci. 2022; 23(1). PMC: 8745562. DOI: 10.3390/ijms23010353. View

Kucia-Tran J, Tulkki V, Scarpini C, Smith S, Wallberg M, Paez-Ribes M . Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma. J Pathol. 2017; 244(3):283-295. DOI: 10.1002/path.5010. View

Bachetti T, Rosamilia F, Bartolucci M, Santamaria G, Mosconi M, Sartori S . The Gene Is Involved in Hirschsprung Associated Enterocolitis Susceptibility through an Altered Downstream Signaling. Int J Mol Sci. 2021; 22(8). PMC: 8067804. DOI: 10.3390/ijms22083831. View

Choy E, Bendit M, McAleer D, Liu F, Feeney M, Brett S . Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials. Arthritis Res Ther. 2013; 15(5):R132. PMC: 3978888. DOI: 10.1186/ar4312. View

West N, Hegazy A, Owens B, Bullers S, Linggi B, Buonocore S . Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017; 23(5):579-589. PMC: 5420447. DOI: 10.1038/nm.4307. View

Nummenmaa E, Hamalainen M, Pemmari A, Moilanen L, Tuure L, Nieminen R . Transient Receptor Potential Ankyrin 1 (TRPA1) Is Involved in Upregulating Interleukin-6 Expression in Osteoarthritic Chondrocyte Models. Int J Mol Sci. 2020; 22(1). PMC: 7794684. DOI: 10.3390/ijms22010087. View

10.

de Souza P, Henning P, Lerner U . Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator. Int J Mol Sci. 2022; 23(6). PMC: 8953253. DOI: 10.3390/ijms23063287. View

11.

Jakob L, Muller T, Rassner M, Kleinfelder H, Veratti P, Mitschke J . Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR. Int J Mol Sci. 2021; 22(21). PMC: 8584221. DOI: 10.3390/ijms222111649. View

12.

Beigel F, Friedrich M, Probst C, Sotlar K, Goke B, Diegelmann J . Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. PLoS One. 2014; 9(4):e93498. PMC: 3977870. DOI: 10.1371/journal.pone.0093498. View

13.

Bailey J, Hang H, Boudreau A, Elks C . Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes. Int J Mol Sci. 2022; 23(9). PMC: 9104719. DOI: 10.3390/ijms23094689. View

14.

Pothoven K, Schleimer R . The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease. Tissue Barriers. 2017; 5(3):e1341367. PMC: 5571776. DOI: 10.1080/21688370.2017.1341367. View

15.

Yu Z, Li Z, Wang C, Pan T, Chang X, Wang X . Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M. Gastric Cancer. 2019; 22(5):955-966. DOI: 10.1007/s10120-019-00934-y. View

16.

Matsuda M, Tsurusaki S, Miyata N, Saijou E, Okochi H, Miyajima A . Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice. Hepatology. 2017; 67(1):296-312. DOI: 10.1002/hep.29421. View

17.

Hermanns H . Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine Growth Factor Rev. 2015; 26(5):545-58. DOI: 10.1016/j.cytogfr.2015.07.006. View

18.

Kun J, Szitter I, Kemeny A, Perkecz A, Kereskai L, Pohoczky K . Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles. PLoS One. 2014; 9(9):e108164. PMC: 4180273. DOI: 10.1371/journal.pone.0108164. View